Global Custom Market Research Reports Provider Company

phone

Adamis Pharmaceuticals Corp (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 32
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. Adamis also provides pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-3000, an HFA inhaled nasal steroid product for the treatment of allergic rhinitis. The company provides its products for patients, physicians, and healthcare organizations. It has operations in Phoenix, Arizona. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Equity Offering 12
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 12
Adamis Pharma Raises USD11 Million in Private Placement of Units 14
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 16
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 18
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 20
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 21
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 22
Debt Offering 23
Adamis Pharma Completes Private Placement Of Debentures For US$0.6 Million 23
Adamis Pharma Completes Private Placement Of Senior Convertible Note For US$0.5 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For US$1 Million 25
Adamis Pharmaceuticals Corp - Key Competitors 26
Adamis Pharmaceuticals Corp - Key Employees 27
Adamis Pharmaceuticals Corp - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Product Approvals 29
Dec 04, 2017: Adamis Pharmaceuticals Announces Submission of Investigational New Drug Application to the FDA for New Product Candidate for the Treatment of Opioid Overdose 29
Other Significant Developments 30
Mar 15, 2018: Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables

List of Tables
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 12
Adamis Pharma Raises USD11 Million in Private Placement of Units 14
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 16
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 18
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 20
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 21
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 22
Adamis Pharma Completes Private Placement Of Debentures For US$0.6 Million 23
Adamis Pharma Completes Private Placement Of Senior Convertible Note For US$0.5 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For US$1 Million 25
Adamis Pharmaceuticals Corp, Key Competitors 26
Adamis Pharmaceuticals Corp, Key Employees 27
Adamis Pharmaceuticals Corp, Subsidiaries 28

List Of Figures

List of Figures
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9

Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases.

View Report

Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases.

View Report

Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports